The FDA has named the first nine medications selected for its national priority review voucher program, which aims to shorten drug review timelines to ...
The FDA launched a new voucher program to fast-track reviews, naming nine experimental drugs for cancer, diabetes, addiction, ...
The US Food and Drug Administration on Thursday announced the first drug manufacturers that will receive expedited reviews as part of a new initiative to reward companies for acquiescing to the Trump ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback